Navigation Links
Regenesance Closes Financing Round
Date:12/2/2010

AMSTERDAM, Dec. 2, 2010 /PRNewswire/ -- Regenesance BV, an Amsterdam-based specialty pharma focusing on developing drugs to treat acute and chronic nerve disorders, announces the closure of its first seed stage financing round.  The investment was made by Life Sciences Fund Amsterdam, an independent venture capital fund established in 2009 to finance biomedical companies in the greater Amsterdam region.

Regenesance was established in November 2009 as a spin-out of the Academic Medical Center Amsterdam (AMC Amsterdam).  The Company was founded on scientific work from AMC researcher Prof. Frank Baas.  He found that an innate part of the immune system ("complement") is activated during nerve degeneration.  Research from his lab suggests that by reducing complement activation it may be possible to treat many diseases such as multiple sclerosis (MS), myasthenia gravis (MG), and traumatic brain injury (TBI).

MS is a chronic autoimmune disease that attacks the body's central nervous system. There is no cure.  Damaged nerves cannot communicate, leading to severe physical and cognitive disabilities. In The Netherlands, about 16,000 people have the disease with about 3 million afflicted worldwide.  Prof. Baas identified compounds that decrease complement activity and significantly reduce disease severity in a research model of MS.  The Company will use funding to advance a lead compound into a pre-clinical testing program required by national regulatory authorities for drug approval.  If successful, it would be as a major step toward conducting a future MS clinical trial with a pharma partner.

The founders of Regenesance are an international team with extensive experience in the management of  a life science company.  Dr. Frank Baas is a co-founder of the Company as well as a Professor of Neurogenetics, Head of the Neurogenetics Laboratory and Genome Analysis facility at AMC.  Co-founders Dr. Kees Fluiter and Dr. Valeria Ramaglia are research scientists working at the Neurogenetics Laboratory.  Dr. Robert L. Buchanan, the Chief Executive Officer of the Company, holds a Ph.D (Biochemistry) from the University of California and was a partner at the law firm of Edwards Angell Palmer & Dodge, Boston MA (USA).  Mikael Orum is a co-founder and Chairman of the Supervisory Board of Regenesance.  He is also a co-founder of several biotechnology companies such as Exiqon A/S  (EXQ:DC) and Cureon A/S (now Santaris Pharma A/S).

Robert L Buchanan, CEO of Regenesance:  "We are grateful to receive the support of Life Sciences Fund Amsterdam.  The funding will help us advance our best compound into pre-clinical development. This step is required by regulatory bodies before conducting a clinical trial. Work in research models suggests that our compounds may be useful in the treatment of MS and perhaps other chronic nerve degeneration disorders for which there is no cure."

Tom Schwarz, Partner at the Life Sciences Fund Amsterdam:  "We are happy with this investment in Regenesance. If successful, the Company's lead compounds will help patients with severe neurodegeneration lead better lives. I am personally looking forward to working closely with the management team as a new member of the company's supervisory board."

Regenesance BV (www.regenesance.com)

Life Sciences Fund Amsterdam (www.lsfamsterdam.nl)


'/>"/>
SOURCE Regenesance
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. BioVascular Inc. Closes $10.87 Million Series C Financing
2. MabVax Therapeutics Closes Two Licensing Agreements With Sloan-Kettering Institute for Cancer Research
3. DNA Therapeutics Closes 2.2 Million EUR Series A Financing Round
4. Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimers Disease
5. Curemark Closes Series A Financing
6. Blue Belt Technologies, Inc. Closes Series A Financing
7. Caraco Pharmaceutical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation
8. American Scientific Resources Inc. Discloses Audited Financials for 2007 and 2008
9. Keraderm Closes on $2.5 Million Investment from NewVa Capital Partners, LP
10. Aethlon Medical Discloses Live Webcast of Todays BIOCOM Presentation
11. Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2021)... ... March 29, 2021 , ... The University of Texas Health Science Center ... San Antonio Multispecialty and Research Hospital, a destination center for research and treatment of ... In a nod to the COVID-19 pandemic, the ceremony was held virtually. , William ...
(Date:3/30/2021)... ... March 29, 2021 , ... Iora Health ... primary care, has partnered with Devoted Health , one of the fastest-growing ... across Maricopa County and provides seniors with the highest-quality care and experience possible, ...
(Date:3/30/2021)... CITY (PRWEB) , ... March 29, 2021 , ... ... has joined the Vaccine Credential Initiative (VCI), a group bringing together leading health ... record of vaccination status, based on open, interoperable standards. By joining the VCI ...
Breaking Medicine Technology:
(Date:3/30/2021)... , ... March 29, 2021 , ... ... the 21st Century , A Virtual Workshop Presented by WCG FDAnews and Cerulean ... 4:30 pm EDT, https://wcg.swoogo.com/modern-sop-and-quality-systems , Are one’s SOPs written for the ...
(Date:3/30/2021)... ... March 29, 2021 , ... According to data released ... reproductive age (13-44) in need of publicly funded contraception live in counties impacted by ... Colorado’s 64 counties have lost some of their Title X resources. , The ...
(Date:3/30/2021)... ... March 29, 2021 , ... Health Literacy Innovations (HLI), a ... confusion due to low health literacy today announces a new partnership with the ... work with ACAP’s member Safety Net Health Plans, those that provide comprehensive health ...
(Date:3/30/2021)... ... ... Dr. Colin Campbell is proud to announce the 1 year anniversary in their new state ... internal medicine and is a primary care specialist who has been practicing for 23 years. ... keep South Jersey healthy one patient at a time. , “Over the past year, Dr. ...
(Date:3/30/2021)... ... March 30, 2021 , ... The COVID-19 ... and survivors; their families; and their caregivers. Crossroads4Hope is addressing the needs of ... emotional support system, MyGo2Support, which meets needs of people impacted by cancer, no ...
Breaking Medicine News(10 mins):